Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,027 | 0 | 0 | 1 | N/A |
| Receivables | N/A | N/A | N/A | 1 | N/A |
| TOTAL | $1,144 | $0 | $0 | $2 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 241 | N/A | N/A | N/A | N/A |
| Intangibles | 0 | 0 | 1 | 1 | 0 |
| Other Non-Current Assets | 60 | 0 | 0 | 0 | 0 |
| TOTAL | $301 | $N/A | $1 | $1 | $N/A |
| Total Assets | $1,445 | $0 | $1 | $3 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 710 | 26 | 18 | 7 | 0 |
| Accrued Expenses | 879 | N/A | N/A | N/A | N/A |
| TOTAL | $1,589 | $26 | $18 | $7 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $10 | $N/A |
| Total Liabilities | $1,589 | $26 | $18 | $17 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 31 | 31 | 26 | N/A |
| Common Shares | 3 | 130 | 120 | 100 | N/A |
| Retained earnings | -5,847 | -246 | -211 | -171 | N/A |
| Other shareholders' equity | 0 | 21 | 21 | 21 | 0 |
| TOTAL | $-144 | $-26 | $-17 | $-14 | $N/A |
| Total Liabilities And Equity | $1,445 | $0 | $1 | $3 | $0 |